Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Laser treatment can effectively reduce unwanted hair growth, particularly for people with fair skin and dark hair.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

High mTORC1 activity slows hair growth and causes it to lose color.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Blocking testosterone speeds up wound healing in males.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Omega-6 fats in certain cells boost male hormone production.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Combining yoga and certain herbs can effectively manage PCOS symptoms and improve quality of life.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.